Entering text into the input field will update the search result below

Loxo Oncology's (LOXO) CEO Josh Bilenker on Q3 2017 Results - Earnings Call Transcript

Nov. 04, 2017 7:10 PM ETLoxo Oncology (LOXO)
SA Transcripts profile picture
SA Transcripts

Loxo Oncology (NASDAQ:LOXO) Q3 2017 Earnings Conference Call November 2, 2017 8:00 AM ET


Jacob Van Naarden - Chief Business Officer

Josh Bilenker - Chief Executive Officer

Jen Burstein - Vice President of Finance


Eric Schmidt - Cowen and Company

Ishmael Asante - Morgan Stanley

Yigal Nochomovitz - Citigroup

Philomena Kamya - Stifel


Good day, ladies and gentlemen, and welcome to the Loxo Oncology Third Quarter 2017 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded. I would now like to introduce your host for today's conference, Mr. Jacob Van Naarden. Sir, you may begin.

Jacob Van Naarden

Thank you, and thank you for joining us today. Before we get started, I'd like to remind you that during this conference call, Loxo Oncology will make certain statements that are considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including our business plans and objectives and timing and success of our clinical trials.

Such forward-looking statements are not guarantees of future performance, and therefore, you should not put undue reliance upon them. These statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from what we expect. I refer you to our SEC filings for a discussion of risk factors that could cause our actual results to differ materially from those discussed today.

Also, please note that we will be discussing certain non-GAAP financial measures on this call. Our GAAP results and GAAP to non-GAAP reconciliations can be found in our earnings press release, which we issued should this morning.

With that, we will turn the call over to our CEO, Dr. Josh Bilenker.

Josh Bilenker

Good morning. We scheduled this brief conference call to begin a new pattern for the company of

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.